Skip to main content
. Author manuscript; available in PMC: 2023 Sep 26.
Published in final edited form as: J Biophotonics. 2022 Dec 23;16(4):e202200291. doi: 10.1002/jbio.202200291

TABLE 1.

Demographic information of IDH-mutant glioma patients recruited for the study

Subject Diagnosis Sex Age Race Ethnicity Device No. of samples
1 Astrocytoma, grade 3 Male 38 White Not Hispanic/Latino S1 2
2 Oligodendroglioma, grade 3 Male 54 White Not Hispanic/Latino S1 7
3 Astrocytoma, grade 4 Male 30 White Hispanic/Latino S1 4
4 Astrocytoma, grade 2 Transgender female 30 White Not Hispanic/Latino S1 and S2 5 (S1) and 3 (S2)
5 Oligodendroglioma, grade 2 Male 36 White Not Hispanic/Latino S1 and S2 4 (S1) and 4 (S2)
6 Astrocytoma, grade 3 Male 26 White Not Hispanic/Latino S1 and S2 3 (S1) and 3 (S2)
7 Oligodendroglioma, grade 2 Female 29 White Not Hispanic/Latino S2 3
8 Oligodendroglioma, grade 3 Female 41 White Not Hispanic/Latino S2 8
9 Astrocytoma, grade 3 Female 39 Unknown Not Hispanic/Latino S2 4
10 Oligodendroglioma, grade 3 Female 40 Unknown Hispanic/Latino S2 6
11 Astrocytoma, grade 4 Female 41 White Not Hispanic/Latino S2 5
12 Astrocytoma, grade 2 Male 26 Black Hispanic/Latino S3 5